142 related articles for article (PubMed ID: 32360466)
1. Mucoadhesive and pH responsive fucoidan-chitosan nanoparticles for the oral delivery of methotrexate.
Coutinho AJ; Costa Lima SA; Afonso CMM; Reis S
Int J Biol Macromol; 2020 Apr; 158():180-188. PubMed ID: 32360466
[TBL] [Abstract][Full Text] [Related]
2. Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.
Barbosa AI; Costa Lima SA; Reis S
Int J Biol Macromol; 2019 Mar; 124():1115-1122. PubMed ID: 30521895
[TBL] [Abstract][Full Text] [Related]
3. Application of pH-Responsive Fucoidan/Chitosan Nanoparticles to Improve Oral Quercetin Delivery.
Barbosa AI; Costa Lima SA; Reis S
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669398
[TBL] [Abstract][Full Text] [Related]
4. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
5. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Fathi M; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
[TBL] [Abstract][Full Text] [Related]
7. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.
Ait Bachir Z; Huang Y; He M; Huang L; Hou X; Chen R; Gao F
Int J Nanomedicine; 2018; 13():5657-5671. PubMed ID: 30288039
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S
Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137
[TBL] [Abstract][Full Text] [Related]
10. Poly-allylamine hydrochloride and fucoidan-based self-assembled polyelectrolyte complex nanoparticles for cancer therapeutics.
Wang P; Kankala RK; Chen B; Long R; Cai D; Liu Y; Wang S
J Biomed Mater Res A; 2019 Feb; 107(2):339-347. PubMed ID: 30548527
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety.
Mehandole A; Mahajan S; Aalhate M; Kumar R; Maji I; Gupta U; Kumar Guru S; Kumar Singh P
Int J Pharm; 2024 Feb; 651():123784. PubMed ID: 38185340
[TBL] [Abstract][Full Text] [Related]
12. Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan-Fucoidan Nanoparticles.
Choi DG; Venkatesan J; Shim MS
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262038
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan from
Flórez-Fernández N; Pontes JF; Guerreiro F; Afonso IT; Lollo G; Torres MD; Domínguez H; Costa AMRD; Grenha A
Mar Drugs; 2023 Feb; 21(2):. PubMed ID: 36827156
[TBL] [Abstract][Full Text] [Related]
15. Development of a new type of multifunctional fucoidan-based nanoparticles for anticancer drug delivery.
Lu KY; Li R; Hsu CH; Lin CW; Chou SC; Tsai ML; Mi FL
Carbohydr Polym; 2017 Jun; 165():410-420. PubMed ID: 28363567
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer.
Nur SG; Buket O; Sezgi K; Cagdas A; Cansu A; Guliz A; Habibe Y; Cigir BA; Yavuz D; Senay HS
Anticancer Agents Med Chem; 2016; 16(8):1038-1042. PubMed ID: 26721835
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
[TBL] [Abstract][Full Text] [Related]
18. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
20. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
